
TY  - JOUR
TI  - 4. Deutscher Hautkrebskongress und 18. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie (ADO) 25. bis 27. September 2008, Berlin
JO  - JDDG: Journal der Deutschen Dermatologischen Gesellschaft
VL  - 6
IS  - 9
SN  - 1610-0379
UR  - https://doi.org/10.1111/j.1610-0387.2008.06860.x
DO  - doi:10.1111/j.1610-0387.2008.06860.x
SP  - 787
EP  - 814
PY  - 2008
ER  - 

TY  - JOUR
TI  - Issue Information - Table of Contents
JO  - Glia
JA  - Glia
VL  - 66
IS  - 12
SN  - 0894-1491
UR  - https://doi.org/10.1002/glia.23228
DO  - doi:10.1002/glia.23228
SP  - 2527
EP  - 2529
PY  - 2018
ER  - 

TY  - JOUR
TI  - Annual meeting program, lecture abstracts, symposium abstracts, workshop abstracts, platform session abstracts, poster session abstracts, author index, nbts program, code of ethics, society guidelines
JO  - Birth Defects Research Part A: Clinical and Molecular Teratology
JA  - Birth Defects Research Part A: Clinical and Molecular Teratology
VL  - 100
IS  - 5
SN  - 1542-0752
UR  - https://doi.org/10.1002/bdra.23251
DO  - doi:10.1002/bdra.23251
SP  - 319
EP  - 452
PY  - 2014
ER  - 

TY  - JOUR
AU  - Ayala-Mar, Sergio
AU  - Donoso-Quezada, Javier
AU  - Gallo-Villanueva, Roberto C.
AU  - Perez-Gonzalez, Victor H.
AU  - González-Valdez, José
TI  - Recent advances and challenges in the recovery and purification of cellular exosomes
JO  - ELECTROPHORESIS
JA  - ELECTROPHORESIS
VL  - 40
IS  - 23-24
SN  - 0173-0835
UR  - https://doi.org/10.1002/elps.201800526
DO  - doi:10.1002/elps.201800526
SP  - 3036
EP  - 3049
KW  - Bioseparations
KW  - Cellular vesicles
KW  - Downstream processing
KW  - Exosomes
KW  - Exosome purification
PY  - 2019
AB  - Abstract Exosomes are nanovesicles secreted by most cellular types that carry important biochemical compounds throughout the body with different purposes, playing a preponderant role in cellular communication. Because of their structure, physicochemical properties and stability, recent studies are focusing in their use as nanocarriers for different therapeutic compounds for the treatment of different diseases ranging from cancer to Parkinson's disease. However, current bioseparation protocols and methodologies are selected based on the final exosome application or intended use and present both advantages and disadvantages when compared among them. In this context, this review aims to present the most important technologies available for exosome isolation while discussing their advantages and disadvantages and the possibilities of being combined with other strategies. This is critical since the development of novel exosome-based therapeutic strategies will be constrained to the effectiveness and yield of the selected downstream purification methodologies for which a thorough understanding of the available technological resources is needed.
ER  - 

TY  - JOUR
TI  - Anatomical Society Summer Meeting 2013: Form and Function in Regenerative Medicine & The Dark Art of Learning Outcomes
JO  - Journal of Anatomy
JA  - J. Anat.
VL  - 224
IS  - 2
SN  - 0021-8782
UR  - https://doi.org/10.1111/joa.12134
DO  - doi:10.1111/joa.12134
SP  - 228
EP  - 249
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Session I (Abstracts 259 – 729)
JO  - Hepatology
JA  - Hepatology
VL  - 64
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.28797
DO  - doi:10.1002/hep.28797
SP  - 136
EP  - 361
PY  - 2016
ER  - 

TY  - JOUR
TI  - ABSTRACTS – Online Panel Discussion (i-Pos)
JO  - International Journal of Rheumatic Diseases
VL  - 11
IS  - s1
SN  - 1756-1841
UR  - https://doi.org/10.1111/j.1479-8077.2008.00373.x
DO  - doi:10.1111/j.1479-8077.2008.00373.x
SP  - A84
EP  - A514
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts from the 43rd American Society of Andrology Annual Meeting
JO  - Andrology
VL  - 6
IS  - S1
SN  - 2047-2919
UR  - https://doi.org/10.1111/andr.12493
DO  - doi:10.1111/andr.12493
SP  - 1
EP  - 98
PY  - 2018
ER  - 

TY  - JOUR
TI  - Poster Discussion Session PDS 1
JO  - Allergy
JA  - Allergy
VL  - 70
IS  - S101
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12717
DO  - doi:10.1111/all.12717
SP  - 113
EP  - 279
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol
VL  - 54
IS  - S2
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.22495
DO  - doi:10.1002/ppul.22495
SP  - S155
EP  - S480
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 109
IS  - S2
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12359
DO  - doi:10.1111/vox.12359
SP  - 1
EP  - 96
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abtracts
JO  - Journal of Medical Primatology
JA  - J Med Primatol
VL  - 45
IS  - 5
SN  - 0047-2565
UR  - https://doi.org/10.1111/jmp.12245
DO  - doi:10.1111/jmp.12245
SP  - 222
EP  - 274
PY  - 2016
ER  - 

TY  - JOUR
AU  - Ebner, Nicole
AU  - Anker, Stefan D.
AU  - von Haehling, Stephan
C8  - JCSM-D-20-00020
TI  - Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
JO  - Journal of Cachexia, Sarcopenia and Muscle
JA  - Journal of Cachexia, Sarcopenia and Muscle
VL  - 11
IS  - 1
SN  - 2190-5991
UR  - https://doi.org/10.1002/jcsm.12552
DO  - doi:10.1002/jcsm.12552
SP  - 274
EP  - 285
KW  - Cachexia
KW  - Muscle wasting
KW  - Sarcopenia
PY  - 2020
AB  - Abstract This article highlights preclinical and clinical studies in the field of wasting disorders that were presented at the 12th Cachexia Conference held in Berlin, Germany, in December 2019. Herein, we summarize the biological and clinical significance of different strategies including antibodies that target Fn14, Spsb 1, SAA1 treatment, ZIP14, a MuRF1 inhibitor, and new diagnostic tools like T-cell communication targets and cut-offs for the detection of skeletal muscle wasting. Of particular interest were the transplantation of mesenchymal stromal cells and muscle stem cell communication. Importantly, one presentation discussed the effect of metal ion transporter ZIP14 loss that reduces cancer-induced cachexia. The potential of anti-ZIP14 antibodies and zinc chelation as anti-cachexia therapy may require testing in patients with cancer cachexia. Large clinical studies were presented such as RePOWER (observational study of patients with primary mitochondrial myopathy), MMPOWER (treatment with elamipretide in patients with primary mitochondrial myopathy), and ACT-ONE as well as new mouse models like the KPP mouse. Promising treatments include rapamycin analogue treatment, anamorelin, elanapril, glucocorticoids, SAA1, antibodies that target Fn14, and a MuRF1 inhibitor. Clinical studies investigated novel approaches, including the role of exercise. It remains a fact, however, that effective treatments for cachexia and wasting disorders are urgently needed in order to improve patients' quality of life and their survival.
ER  - 

TY  - JOUR
TI  - Symposia
JO  - FEBS Open Bio
JA  - FEBS Open Bio
VL  - 8
IS  - S1
SN  - 2211-5463
UR  - https://doi.org/10.1002/2211-5463.12449
DO  - doi:10.1002/2211-5463.12449
SP  - 10
EP  - 79
PY  - 2018
ER  - 

TY  - JOUR
TI  - 55th Annual Teratology Society Meeting
JO  - Birth Defects Research Part A: Clinical and Molecular Teratology
JA  - Birth Defects Research Part A: Clinical and Molecular Teratology
VL  - 103
IS  - 5
SN  - 1542-0752
UR  - https://doi.org/10.1002/bdra.23387
DO  - doi:10.1002/bdra.23387
SP  - 311
EP  - 468
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Sessions Wednesday/Thursday
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 150
IS  - S1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.14777
DO  - doi:10.1111/jnc.14777
SP  - 162
EP  - 251
PY  - 2019
ER  - 

TY  - JOUR
TI  - The 2017 Annual Meeting of the International Genetic Epidemiology Society
JO  - Genetic Epidemiology
JA  - Genet. Epidemiol.
VL  - 41
IS  - 7
SN  - 0741-0395
UR  - https://doi.org/10.1002/gepi.22062
DO  - doi:10.1002/gepi.22062
SP  - 644
EP  - 709
PY  - 2017
ER  - 

TY  - JOUR
TI  - Keyword Index
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04382.x
DO  - doi:10.1111/j.1538-7836.2011.04382.x
SP  - 1028
EP  - 1055
PY  - 2011
ER  - 

TY  - JOUR
TI  - Workshop Sessions
JO  - Immunology
VL  - 137
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12001
DO  - doi:10.1111/imm.12001
SP  - 1
EP  - 184
PY  - 2012
ER  - 

TY  - JOUR
TI  - Danish Association for Cancer Research Annual meeting 2006
JO  - APMIS
VL  - 114
IS  - 3
SN  - 0903-4641
UR  - https://doi.org/10.1111/j.1600-0463.2006..x
DO  - doi:10.1111/j.1600-0463.2006..x
SP  - 163
EP  - 191
PY  - 2006
ER  - 
